Director/PDMR Shareholding

RNS Number : 9963X

Spectral MD Holdings, Ltd.

11 January 2022

 

11 January 2022

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company" or the Group")  

Director/PDMR Shareholding

LONDON, U.K AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, has been notified that on 10 January 2022, Gerald Beaney, a non-executive director, has purchased 13,333 shares of common stock of US$0.001 ("Common Stock") each in the capital of the Company ("Shares") at a price of 37.5 pence per Share for a total consideration of £5,000.

As a result, Gerald Beaney's beneficial interest in the Company is 30,283 shares of Common Stock , representing 0.02% of the total issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gerald Beaney
2	Reason for the notification
a)	Position/status	Non-executive director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spectral MD Holdings, Ltd
b)	LEI	213800VXW1FVGWTCKL44
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Shares of common stock of US$0.001 each
	Identification code	USU8457V1099
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volume(s)		Price(s) Volume(s) 37.5p 13,333
d)	Aggregated information Volume Price	13,333 £4,999.88
e)	Date of the transaction	10 January 2022
f)	Place of the transaction	London Stock Exchange

For further information, please contact:
Spectral MD Holdings, Ltd.			https://investors.spectralmd.com/
Wensheng Fan, Chief Executive Officer Nils Windler, Chief Financial Officer			via Walbrook PR
SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)			[phone]
Stuart Gledhill / Caroline Rowe (Corporate Finance) Vadim Alexandre / Rob Rees (Sales and Corporate Broking)
Stifel Nicolaus Europe Limited (Joint Broker)			[phone]
Charles Hoare / Ben Maddison / Will Palmer-Brown
Walbrook PR Ltd (Media & Investor Relations)	[phone] or [e-mail]
Paul McManus / Sam Allen Louis Ashe-Jepson		[phone]/ [phone] [phone]

 

END

 

 

DSHDGGDBXDBDGDG